Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection.

Ciancarella V, Lembo-Fazio L, Paciello I, Bruno AK, Jaillon S, Berardi S, Barbagallo M, Meron-Sudai S, Cohen D, Molinaro A, Rossi G, Garlanda C, Bernardini ML.

PLoS Pathog. 2018 Dec 7;14(12):e1007469. doi: 10.1371/journal.ppat.1007469. eCollection 2018 Dec.

2.

Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex.

Lembo-Fazio L, Billod JM, Di Lorenzo F, Paciello I, Pallach M, Vaz-Francisco S, Holgado A, Beyaert R, Fresno M, Shimoyama A, Lanzetta R, Fukase K, Gully D, Giraud E, Martín-Santamaría S, Bernardini ML, Silipo A.

Front Immunol. 2018 Aug 14;9:1888. doi: 10.3389/fimmu.2018.01888. eCollection 2018.

3.

Dynamic density shaping of photokinetic E. coli.

Frangipane G, Dell'Arciprete D, Petracchini S, Maggi C, Saglimbeni F, Bianchi S, Vizsnyiczai G, Bernardini ML, Di Leonardo R.

Elife. 2018 Aug 14;7. pii: e36608. doi: 10.7554/eLife.36608.

4.

The Deep-Sea Polyextremophile Halobacteroides lacunaris TB21 Rough-Type LPS: Structure and Inhibitory Activity towards Toxic LPS.

Lorenzo FD, Palmigiano A, Paciello I, Pallach M, Garozzo D, Bernardini ML, Cono V, Yakimov MM, Molinaro A, Silipo A.

Mar Drugs. 2017 Jun 27;15(7). pii: E201. doi: 10.3390/md15070201.

5.

The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells.

D'Elios MM, Vallese F, Capitani N, Benagiano M, Bernardini ML, Rossi M, Rossi GP, Ferrari M, Baldari CT, Zanotti G, de Bernard M, Codolo G.

Sci Rep. 2017 Jan 11;7:40515. doi: 10.1038/srep40515.

6.

The Lipid A from Rhodopseudomonas palustris Strain BisA53 LPS Possesses a Unique Structure and Low Immunostimulant Properties.

Di Lorenzo F, Palmigiano A, Al Bitar-Nehme S, Sturiale L, Duda KA, Gully D, Lanzetta R, Giraud E, Garozzo D, Bernardini ML, Molinaro A, Silipo A.

Chemistry. 2017 Mar 13;23(15):3637-3647. doi: 10.1002/chem.201604379. Epub 2016 Dec 22.

PMID:
28004420
7.

The Orchestra and Its Maestro: Shigella's Fine-Tuning of the Inflammasome Platforms.

Hermansson AK, Paciello I, Bernardini ML.

Curr Top Microbiol Immunol. 2016;397:91-115. doi: 10.1007/978-3-319-41171-2_5. Review.

PMID:
27460806
8.

The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region.

Ganzetti G, Campanati A, Bernardini ML, Bettacchi A, Brandozzi G, Brisigotti V, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.

G Ital Dermatol Venereol. 2016 Aug;151(4):340-6. Epub 2015 Jun 19.

PMID:
26091276
9.

Determination of the structure of the O-antigen and the lipid A from the entomopathogenic bacterium Pseudomonas entomophila lipopolysaccharide along with its immunological properties.

Speciale I, Paciello I, Fazio LL, Sturiale L, Palmigiano A, Lanzetta R, Parrilli M, Garozzo D, Lemaitre B, Bernardini ML, Molinaro A, De Castro C.

Carbohydr Res. 2015 Aug 14;412:20-7. doi: 10.1016/j.carres.2015.04.017. Epub 2015 May 1.

PMID:
25996527
10.

Thermophiles as potential source of novel endotoxin antagonists: the full structure and bioactivity of the lipo-oligosaccharide from Thermomonas hydrothermalis.

Di Lorenzo F, Paciello I, Fazio LL, Albuquerque L, Sturiale L, da Costa MS, Lanzetta R, Parrilli M, Garozzo D, Bernardini ML, Silipo DA, Molinaro A.

Chembiochem. 2014 Sep 22;15(14):2146-55. doi: 10.1002/cbic.201402233. Epub 2014 Aug 29.

PMID:
25171597
11.

Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation.

Paciello I, Silipo A, Lembo-Fazio L, Curcurù L, Zumsteg A, Noël G, Ciancarella V, Sturiale L, Molinaro A, Bernardini ML.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):E4345-54. doi: 10.1073/pnas.1303641110. Epub 2013 Oct 28. Erratum in: Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20843.

12.

Characterization of SfPgdA, a Shigella flexneri peptidoglycan deacetylase required for bacterial persistence within polymorphonuclear neutrophils.

Kaoukab-Raji A, Biskri L, Bernardini ML, Allaoui A.

Microbes Infect. 2012 Jul;14(7-8):619-27. doi: 10.1016/j.micinf.2012.01.009. Epub 2012 Jan 23.

PMID:
22307019
13.

Effective interactions between colloidal particles suspended in a bath of swimming cells.

Angelani L, Maggi C, Bernardini ML, Rizzo A, Di Leonardo R.

Phys Rev Lett. 2011 Sep 23;107(13):138302. Epub 2011 Sep 19.

PMID:
22026908
14.

Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia.

Cigana C, Lorè NI, Bernardini ML, Bragonzi A.

J Biomed Biotechnol. 2011;2011:852513. doi: 10.1155/2011/852513. Epub 2011 Jul 14.

15.

Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivo.

Lembo-Fazio L, Nigro G, Noël G, Rossi G, Chiara F, Tsilingiri K, Rescigno M, Rasola A, Bernardini ML.

Cell Death Dis. 2011 Feb 24;2:e122. doi: 10.1038/cddis.2011.4.

16.

Clinical, power Doppler sonography and histological assessment of the psoriatic plaque: short-term monitoring in patients treated with etanercept.

Gutierrez M, De Angelis R, Bernardini ML, Filippucci E, Goteri G, Brandozzi G, Lemme G, Campanati A, Grassi W, Offidani A.

Br J Dermatol. 2011 Jan;164(1):33-7. doi: 10.1111/j.1365-2133.2010.10026.x. Epub 2010 Nov 11.

PMID:
21070199
17.

Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.

Cigana C, Curcurù L, Leone MR, Ieranò T, Lorè NI, Bianconi I, Silipo A, Cozzolino F, Lanzetta R, Molinaro A, Bernardini ML, Bragonzi A.

PLoS One. 2009 Dec 23;4(12):e8439. doi: 10.1371/journal.pone.0008439.

18.

Purely cutaneous Langerhans' cell histiocytosis in an adult woman.

Campanati A, Simonetti O, Marconi B, Giuliodori K, Ganzetti G, Brandozzi G, Bernardini ML, Ranaldi R, Offidani A.

Acta Derm Venereol. 2009;89(3):299-301. doi: 10.2340/00015555-0614. No abstract available.

19.

Adhesion molecules and cytokine profile in ileal tissue of sheep infected with Mycobacterium avium subsp. paratuberculosis.

Rossi G, Nigro G, Tattoli I, Vincenzetti S, Mariani P, Magi GE, Renzoni G, Taccini E, Bernardini ML.

Microbes Infect. 2009 May-Jun;11(6-7):698-706. doi: 10.1016/j.micinf.2009.04.006. Epub 2009 Apr 17.

PMID:
19376260
20.

Bullous-vesicular variant of mycosis fungoides presenting as erythema annulare centrifugum: a case report.

Bernardini ML, Brandozzi G, Campanati A, Giangiacomi M, Offidani A.

J Eur Acad Dermatol Venereol. 2009 Jul;23(7):839-40. doi: 10.1111/j.1468-3083.2008.03030.x. Epub 2009 Jan 19. No abstract available.

PMID:
19175475
21.

Intracellular bacteriolysis triggers a massive apoptotic cell death in Shigella-infected epithelial cells.

Tattoli I, Lembo-Fazio L, Nigro G, Carneiro LA, Ferraro E, Rossi G, Martino MC, de Stefano ME, Cecconi F, Girardin SE, Philpott DJ, Bernardini ML.

Microbes Infect. 2008 Aug-Sep;10(10-11):1114-23. doi: 10.1016/j.micinf.2008.06.004. Epub 2008 Jun 18.

PMID:
18606244
22.

IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexenri.

Hachani A, Biskri L, Rossi G, Marty A, Ménard R, Sansonetti P, Parsot C, Van Nhieu GT, Bernardini ML, Allaoui A.

Microbes Infect. 2008 Mar;10(3):260-8. doi: 10.1016/j.micinf.2007.11.011. Epub 2007 Dec 8.

PMID:
18316224
23.

Full structural characterization of Shigella flexneri M90T serotype 5 wild-type R-LPS and its delta galU mutant: glycine residue location in the inner core of the lipopolysaccharide.

Molinaro A, Silipo A, Castro CD, Sturiale L, Nigro G, Garozzo D, Bernardini ML, Lanzetta R, Parrilli M.

Glycobiology. 2008 Mar;18(3):260-9. doi: 10.1093/glycob/cwm140. Epub 2008 Jan 3.

PMID:
18174310
24.

Muramylpeptide shedding modulates cell sensing of Shigella flexneri.

Nigro G, Fazio LL, Martino MC, Rossi G, Tattoli I, Liparoti V, De Castro C, Molinaro A, Philpott DJ, Bernardini ML.

Cell Microbiol. 2008 Mar;10(3):682-95. Epub 2007 Nov 27.

PMID:
18042252
25.

CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.

Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Stramazzotti D, Morichetti D, Bernardini ML, Mannello B, Fabris G, Offidani A.

Br J Dermatol. 2007 Dec;157(6):1155-60. Epub 2007 Oct 4.

PMID:
17916208
26.

Indications for excision of nevi and melanoma diagnosed in a pediatric surgical unit.

Zangari A, Bernardini ML, Tallarico R, Ilari M, Giangiacomi M, Offidani AM, Martino A.

J Pediatr Surg. 2007 Aug;42(8):1412-6.

PMID:
17706506
27.

Atypical neurothekeoma: a new case and review of the literature.

Campanati A, Brandozzi G, Sisti S, Bernardini ML, Offidani AM.

J Cutan Pathol. 2007 May;34(5):435-7.

PMID:
17448203
28.

Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study.

Campanati A, Bernardini ML, Gesuita R, Offidani A.

Eur J Dermatol. 2007 Jan-Feb;17(1):52-4. Epub 2007 Feb 27.

PMID:
17324828
29.

Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.

Bernardini ML, Cangiotti AM, Zamponi N, Porfiri L, Cinti S, Offidani A.

J Cutan Pathol. 2007 Mar;34(3):270-5.

PMID:
17302612
30.

Erythema multiforme following live attenuated trivalent measles-mumps-rubella vaccine.

Bernardini ML, D'Angelo G, Oggiano N, Campanati A, Ficcadenti A, Coppa GV, Offidani A.

Acta Derm Venereol. 2006;86(4):359-60. No abstract available.

31.

Mucosal lymphoid infiltrate dominates colonic pathological changes in murine experimental shigellosis.

Martino MC, Rossi G, Martini I, Tattoli I, Chiavolini D, Phalipon A, Sansonetti PJ, Bernardini ML.

J Infect Dis. 2005 Jul 1;192(1):136-48. Epub 2005 May 31.

PMID:
15942903
32.

Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri.

Le Gall T, Mavris M, Martino MC, Bernardini ML, Denamur E, Parsot C.

Microbiology. 2005 Mar;151(Pt 3):951-62.

PMID:
15758240
33.

Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years.

Simonetti O, Bernardini ML, Arzeni D, Cellini A, Barchiesi F, Offidani A.

Mycopathologia. 2004 Oct;158(3):271-4.

PMID:
15645167
34.

Intravenous infection of virulent shigellae causes fulminant hepatitis in mice.

Martino MC, Rossi G, Tattoli I, Martini I, Chiavolini D, Cortese G, Pozzi G, Bernardini ML.

Cell Microbiol. 2005 Jan;7(1):115-27.

PMID:
15617528
35.
36.

Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants.

Cersini A, Martino MC, Martini I, Rossi G, Bernardini ML.

Infect Immun. 2003 Dec;71(12):7002-13.

37.

Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.

Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A.

Cancer. 2002 Nov 1;95(9):1963-70.

38.

Selection of Shigella flexneri candidate virulence genes specifically induced in bacteria resident in host cell cytoplasm.

Bartoleschi C, Pardini MC, Scaringi C, Martino MC, Pazzani C, Bernardini ML.

Cell Microbiol. 2002 Sep;4(9):613-26.

PMID:
12390353
39.

General practitioners' accuracy in diagnosing skin cancers.

Offidani A, Simonetti O, Bernardini ML, Alpagut A, Cellini A, Bossi G.

Dermatology. 2002;205(2):127-30.

PMID:
12218226
40.

Role of cytomegalovirus replication in alopecia areata pathogenesis.

Offidani A, Amerio P, Bernardini ML, Feliciani C, Bossi G.

J Cutan Med Surg. 2000 Apr;4(2):63-5.

PMID:
11179926
41.

Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.

Bernardini ML, Arondel J, Martini I, Aidara A, Sansonetti PJ.

Infect Immun. 2001 Feb;69(2):1072-83.

42.

Hypereosinophilic dermatosis: skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome?

Offidani A, Bernardini ML, Simonetti O, Simoncini C, Giangiacomi M, Bossi G.

Br J Dermatol. 2000 Sep;143(3):675-7. No abstract available.

PMID:
10971369
43.

Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants.

Cersini A, Salvia AM, Bernardini ML.

Infect Immun. 1998 Feb;66(2):549-57.

44.

OmpC is involved in invasion of epithelial cells by Shigella flexneri.

Bernardini ML, Sanna MG, Fontaine A, Sansonetti PJ.

Infect Immun. 1993 Sep;61(9):3625-35.

45.

Environmental regulation of Shigella virulence.

Maurelli AT, Hromockyj AE, Bernardini ML.

Curr Top Microbiol Immunol. 1992;180:95-116. Review. No abstract available.

PMID:
1324135
46.
47.

The two-component regulatory system ompR-envZ controls the virulence of Shigella flexneri.

Bernardini ML, Fontaine A, Sansonetti PJ.

J Bacteriol. 1990 Nov;172(11):6274-81.

48.

Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin.

Bernardini ML, Mounier J, d'Hauteville H, Coquis-Rondon M, Sansonetti PJ.

Proc Natl Acad Sci U S A. 1989 May;86(10):3867-71.

Supplemental Content

Loading ...
Support Center